Sponsor Pipeline

Shanghai Shengdi Pharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
3
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07168200 A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy… Advanced Cervical Cancer Recruiting
NCT07522151 Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or… Locally Advanced Gastric or Gastroesophageal Junction Cancer Recruiting
Phase 2/3
NCT06335355 A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in… Non-squamous Non-small Cell Lung Cancer Not Yet Recruiting
Phase 1/2
NCT07231211 A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors Solid Tumors Recruiting
Disease Areas
Get alerts when Shanghai Shengdi Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free